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1. Introduction 
Endophthalmitis is a severe, purulent intraocular inflammation of the intraocular cavities 
(i.e. the aqueous or vitreous humor) usually caused by infection. Endophthalmitis can be 
exogenous or endogenous.  
Exogenous is caused by trauma or surgery (most commonly cataract extraction).  
Approximately 70 percent of cases occur as a direct complication of intraocular surgery. 
Such post-operative endophthalmitis may be acute (presenting within 6 weeks of surgery) 
or chronic. Incidence of acute endophthalmitis following cataract extraction have been 
reported between 0.072% and 0.13% in various studies.1-4 The most common infecting 
organisms following cataract extraction are the coagulase-negative Staphylococcus spp., 
especially S. epidermidis.5,6 
Endogenous (metastatic) endophthalmitis is caused by organisms reaching the eye via blood 
stream. In endogenous endophthalmitis, blood-borne organisms permeate the blood-ocular 
barrier either by direct invasion (e.g. septic emboli) or by changes in vascular endothelium 
caused by substrates released during infection. Destruction of intraocular tissues may be 
due to direct invasion by the organism and/or from inflammatory mediators of the immune 
response. It is seen in patients in whom body immunity is compromised e.g. chronic 
alcoholics, HIV patients, malignancy, renal transplant patients. 
The management of endophthalmitis revolves around intense medical treatment and 
surgical intervention, with salvaging the eye and vision as primary aim (Table 1). Diagnosis 
and intensive treatment at the earliest possible time is essential. The timing is controversial 
and needs surgeon’s judgment regarding immediate or delayed surgical intervention taking 
into account the risk and benefit to the patient (Table 2).  
2. Endophthalmitis Vitrectomy Study (EVS) 
Before the EVS, there were widely divergent opinions regarding the role of vitrectomy in 
endophthalmitis management, ranging from vitrectomy for all endophthalmitis cases to the 
use of vitrectomy for only the most severe cases with greater inflammation, worse visual 
acuity, and more rapid onset. Great strides were made for post cataract endophthalmitis 
with the execution of the prospective Endophthalmitis Vitrectomy Study (EVS) in the 1990s  
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Aim's of management 
 Kill the organism; 
 Remove the inflammatory debris from the vitreous cavity 
 Block the inflammatory cascade and its effects on the retina 
 Treat the complications of the infection 
Table 1. Summarizes the aims of management in endophthalmitis. 
 
Immediate vitrectomy: 
1. Obtains early sample for vitreous culture 
and to start specific treatment. 
2. Clears ocular media to assess disease 
severity and treatment response. 
3. Removes toxic products/ vitreous scaffold 
for the formation of scar tissue as also the 
vitreous membranes which could lead to 
tractional retinal detachment. 
4. Reduces bacterial load 
5. Intravitreal antibiotics at the end of 
procedure. 
6. Increases the antibiotics concentration in 
the eye. It also facilitates better diffusion and 
penetration of antibiotics as they are 
delivered directly to the infected site during 
vitrectomy.  
7. Increases retinal oxygenization 
8. Reduces the incidence and severity of 
retinal, especially macular, complications. 
Delayed vitrectomy: 
1. Easier to operate on a non inflamed eye 
 
2. Tissue is less friable 
 
3. Visualization is better 
Table 2. Denotes the advantages of performing immediate vitrectomy over delayed 
vitrectomy in endophthalmitis. 
to lay the guidelines for the timings of vitrectomy.7 The EVS evaluated the role of 
immediate pars plana vitrectomy versus intraocular antibiotic injection (TAP) and 
systemic antibiotics in the treatment of acute postoperative endophthalmitis. Acute post-
operative endophthalmitis (presenting within 6 weeks) and secondary IOL implantation 
patients who were having an initial visual acuity between 20/50 and light perception, and 
had a view sufficient to perform a vitrectomy were included in the study. 420 patients 
were randomized to immediate initial TAP or vitrectomy. There was no difference in final 
visual outcomes in patients who underwent initial TAP or vitrectomy if presenting visual 
acuity was better than light perception. However, in patients presenting with light 
perception vision, those who underwent initial vitrectomy were 3 times more likely to 
achieve 20/40 vision or better, twice as likely to maintain 20/100 vision or better, and had 
a nearly 50% reduction in the risk of severe visual loss (< 5/200), compared to patients 
who underwent TAP. No long-term difference occurred in media clarity between the 
treatment groups. 
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3. Pitfalls of EVS 
Although EVS study did give us first insight and guidelines, but there were various pitfalls 
present in the study itself. Since the EVS specifically excluded patients with postoperative 
endophthalmitis who underwent any procedure other than cataract surgery, results cannot 
be generalized to every endophthalmitis. In patients with conjunctival filtering bleb-
associated endophthalmitis, earlier vitrectomy is preferred because of more profound 
inflammation and the increased probability of more virulent organisms. Further traumatic 
endophthalmitis (especially associated with intraocular foreign body) presents with intense 
inflammation and if vitrectomy is not done early, it can lead to loss of the eye. Chronic post-
operative endophthalmitis (caused by P.acne or fungus) has been associated with high rates 
of persistent inflammation. Vitrectomy with special attention to either partial or total 
capsular bag excision with or without IOL removal has been reported effective in 
eradicating inflammation as compared to TAP alone. Further newer generations systemic 
antibiotics can achieve good concentration inside the eye, and help in reducing the infection 
and achieving having good outcome. Technological advancements in vitreoretinal surgery 
since EVS have minimized the risks associated with vitrectomy favoring the initial use of 
vitrectomy in less severe cases also.  
4. Procedure 
Before starting surgical intervention, necessary instruments and drugs should be ready. 
(Table 3)  
 
 Instruments:  Disposables:  Medication:
- Eye speculum - Surgical drape - 0.5% Bupivacaine 
- Forceps - Sterile surgical gloves - 2% lidocaine 
- Irrigation cannula - 10% povidone iodine swabs - 150 IE Hyaluronidase 
- Corneo-scleral scissors - 5% povidone iodine solution - 0.1 cc Cetazidime (22.5 
mg/ml) 
- Vitrectome hand piece and 
unit 
- Three plastic cups - 0.1 cc Vancomycin (10 
mg/ml) 
- Barraquer forceps - One syringe (6.0 cc) - 0.1 cc Dexamethasone (4 
mg/ml) 
 - Four syringes (1.0 cc)  
 - Cotton tip applicators  
 - Three 30-gauge needles  
 - Three sterile caps for 
syringes 
 
 - 4×4-cm sterile cotton pads  
 - 23-gauge microvitreoretinal 
blade 
 
 - Eye pad and tape  
Table 3. Signifies equipment required for the management of endophthalmitis 
www.intechopen.com
 
Vitrectomy 
 
4 
5. Vitreous tap 
This procedure is preferably done under peribulbar anaesthesia using 2% lignocaine and/or 
0.5% bupivacaine. As with routine surgery, eye has to be prepared using povidone-iodine 
scrub followed by sterile drape. Vitreous tap can be done either with a needle attached to a 
syringe or using the vitreous cutter. 
A 5 cc syringe and small gauge needle (23-26G) is preferred for the aspiration. A 23 gauge 
butterfly needle can also be used for this purpose. The needle is inserted approximately 3-
4mm (3mm for aphakic, 3.5mm for pseudophakic and 4 mm for phakic patients) from the 
limbus into the mid vitreous cavity. Gentle aspiration is applied and 0.2-0.3 ml of fluid is 
aspirated. If vitreous is not aspirated, the needle tip can be carefully moved in an attempt 
to locate a pocket of liquid vitreous. If after several attempts a vitreous specimen cannot 
be obtained the procedure should be terminated as suction can lead to iatrogenic retinal 
tears formation and subsequent retinal detachment.In such kind of cases one could use 
vitreous cutter to tap the vitreous. Intraocular antibiotics can be injected at the same 
sitting. Vancomycin (1mg in 0.1 ml), and ceftazidime (2.25 mg in 0.1ml) are the preferred 
drugs initially till the final microbiology report is available. Doses of various intravitreal 
antibiotic chart should be prepared and should be pasted in operation theatre as doses are 
confusing, and slight mistake in making can lead to adverse events (e.g. toxicity). 
Common intravitreal antibiotics doses and their mechanism of action have been described 
in (Table 4). 
6. Vitrectomy 
The surgical technique of vitrectomy is similar to the standard three-port vitrectomy with 
few exceptions. Securing the infusion cannula correctly is very important and its 
visualization through an inflammed choroid and hazy media can be a difficult thing. A 
longer infusion cannula (6-mm cannula), is generally recommended in these situations. If 
cannula is still not visible then a good alternative is to use the hand held infusion cannula 
and clear vitreous exudates with the cutter till the regular cannula is visible through the 
pupil. If the epithelium is edematous, its removal may be necessary. Scraping the epithelium 
can increases the visibility and thus increases the success rate of the surgery. If the stroma 
also has significant edema, pressing a dry sponge against it, or using topical high-
concentration glucose may increase visibility. The anterior chamber often contains 
hypopyon and exudative membrane which interferes with adequate visualization. In 
pseudophakic patients a 26-gauge instrument, such as, a hypodermic needle could be 
introduced through the limbus to clear the hypopyon and any inflammatory membrane 
without explantation of the IOL or anterior chamber maintainer can be used and 
inflammatory material over IOL can be aspirated to make visualization better. Vitreous 
aspirate should be the first step of the surgery before starting the infusion to get an 
undiluted sample for culture. Vitreous sample is collected by short tubing attached to the 
suction port of the vitrectomy probe. The suction is operated manually by syringe attached 
to the tubing. Infusion fluid bottle should be at a low height. Care should be taken not to 
cause too much hypotony while taking vitreous aspirate and as soon as biopsy is obtained, 
infusion should be switched on, and suction should be very slow so as not to cause any 
inadvertent traction leading to break formation. The aim of vitrectomy in endophthalmitis is  
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ANTIBIOTICS DOSE MECHANISM OF ACTION 
Amikacin 0.4mg/0.1ml Inhibit protein synthesis by binding to the 30S 
rRNA molecule of the bacterial ribosome  
Kanamycin 0.5mg/0.1ml Inhibit protein synthesis by binding to the 30S 
rRNA molecule of the bacterial ribosome  
Tobramycin 0.4mg/0.1ml Inhibit protein synthesis by binding to the 30S 
rRNA molecule of the bacterial ribosome  
Vancomycin 1.0mg/o.1ml Inhibit protein synthesis by binding to the 30S 
rRNA molecule of the bacterial ribosome  
Ampicillin 5.omg/0.1ml Inhibition of bacterial cell wall synthesis by 
preventing the cross linking of peptides on the 
mucosaccharide chains  
Carbenicillin 2.0mg/0.1ml Inhibition of bacterial cell wall synthesis by 
preventing the cross linking of peptides on the 
mucosaccharide chains 
Methicillin 2.0mg/0.1ml Inhibition of bacterial cell wall synthesis by 
preventing the cross linking of peptides on the 
mucosaccharide chains 
Erythromycin 0.5mg/0.1ml Inhibit protein synthesis by binding to the 23S 
rRNA molecule (in the 50S subunit) of the bacterial 
ribosome blocking the exit of the growing peptide 
chain 
Gentamicin 0.2mg/0.1ml Inhibit protein synthesis by binding to the 30S 
rRNA molecule of the bacterial ribosome 
Cefazoline 2.0mg/0.1ml Inhibition of bacterial cell wall synthesis by 
preventing the cross linking of peptides on the 
mucosaccharide chains 
Ceftazidime 2.25mg/0.1ml Inhibition of bacterial cell wall synthesis by 
preventing the cross linking of peptides on the 
mucosaccharide chains 
Imipenum 0.05mg/0.1ml Inhibition of synthesis of the peptidoglycan layer of 
bacterial cell walls 
Tazobactum 2.25mg/0.1ml Inhibition of bacterial cell wall synthesis 
ANTIFUNGALS
Amphotericin B 0.5mg/0.1ml Associates with ergosterol forming a 
transmembrane channel that leads to monovalent 
ion (K+, Na+, H+ and Cl−) leakage 
Voriconazole 0.05mg/0.1ml Inhibition of fungal-cytochrome P-450-mediated 14 
alpha- lanosterol demethylation, leading to an 
accumulation of 14 alpha-methyl sterols which 
results in loss of ergosterol in the cell wall 
Table 4. Summarizes the dose of intravitreal antimicrobial agents and mechanism of actions 
of these drugs used in the management of endophthalmitis. 
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only to perform a "core" vitrectomy. There should be minimal traction on the inflamed and 
friable retina. To avoid unnecessary traction, vitrectomy should be performed with low 
suction and high cut rate. PVD (posterior vitreous detachment) induction should be avoided 
as it can lead to traction and can lead to break formation leading to rhegmatogenous retinal 
detachment. IOL explantation is not necessary in all the cases of pseudophakic 
endophthalmitis.8, 9 Explantation of the IOL is mostly necessary in fungal endophthalmitis 
and in P. acnes endophthalmitis, however one should try to preserve IOL as far as possible 
and perform a generous capsulotomy, either to retain or exchange the IOL and to inject 
intraocular antibiotic near the remaining part of the capsular bag.10 IOL explantation should 
be reserved as a last option.  
7. Endophthalmitis in phakic patients 
The above mentioned procedure holds good if patients is aphakic or having intraocular 
lens (IOL) implanted. Endophthalmitis in phakic patients presents with difficult situation 
(e.g. traumatic or endogenous endophthalmitis). Lens can be clear with major 
involvement of posterior segment or lens can be involved (lens abscess). Preserving the 
lens has the advantage of preserving the natural lens, and it increases the half-life of 
intraocular antibiotics.32 In a study by Huang et al, authors were able to control the 
infections in all the eyes (12 eyes) without removing the natural lens.33 Six of 12 eyes 
achieved 20/80 or better visual acuity with an average follow-up time of 13 months. Six of 
eight eyes treated with pars plana vitrectomy and intraocular antibiotic injection achieved 
this level of visual acuity in contrast to none of four eyes treated with only intraocular 
antibiotic injection. 33 If infection is severe and media is hazy because of lens, one should 
not be hesitant to remove lens, so as to have better visualization to complete vitrectomy 
and achieve good visual outcome. IOL placement can be done as a secondary procedure at 
later date once infection is well controlled. However one should try to preserve lens as far 
as possible.  
8. Extent of vitrectomy 
There is a variable consensus on the extent of the vitrectomy. According to the EVS study, 
only core vitrectomy should be done and posterior vitreous detachment (PVD) should be 
avoided as far as possible, as retina is inflammed and friable and there are high chances of 
retinal break formation. Core vitrectomy comprises the removal of anterior and central 
vitreous first, followed by posterior central vitreous. No attempt is made to enter vitreous 
base. No posterior hyaloid cleaning is done. Core vitrectomy is only done in central area 
and peripheral vitrectomy should be avoided. End point of vitrectomy is either when red 
glow is visible or disc with 1st order vessels are visible. Intravitreal antibiotics are injected 
at the end of the procedure. As opposed to conservative vitrectomy (recommended by 
EVS and followed mostly), induction of PVD and little more aggressive vitrectomy was 
advocated in complete and early vitrectomy for endophthalmitis (CEVE).11 Authors in 
their series of 47 consecutive postoperative endophthalmitis patients found statistically 
significantly better anatomical and functional results with CEVE than in either 
management arm in the EVS. The authors attribute this improvement to vitrectomy being 
early and complete, and to its being the primary line of treatment, rather than being 
applied as a last resort.11 According to author PVD induction should only be done at 
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posterior pole over non-necrotic area. PVD should not be attempted aggressively or 
should not be extended beyond equator, as there are high chances of teat formation with 
subsequent retinal detachment. Further posterior exudates over the surface of retina can 
be aspirated by soft tip flute needle. PVD induction will have direct access of antibiotics to 
retinal surfaces and removes posterior vitreous scaffold for infection, leading to early 
recovery.  
During vitrectomy surgeon should be extremely careful to cut anything as there are several 
vitreous layers and membranes can be present and sometimes it is very difficult to 
differentiate them from the retina esp. when there are streaks of blood among the layers, 
giving the appearance of a detached retina. Further retina can become necrotic in 
endophthalmitis leading to white avascular appearance simulating vitreous layers, and even 
on cutting it does not bleed. A less experienced or careful surgeon may remove large area of 
the retina before realizing it. To avoid this complication, surgeon should not cut any 
membrane without visualization. Vitrectomy should be started from behind the lens and 
then slowly one should advance towards the retina. If there is doubt regarding the 
structures, its better to do vitrectomy in nasal quadrant to avoid inadvertent injury to the 
fovea. If still it is not possible to differentiate the retina from the vitreous, its better to do 
very minimal vitrectomy and plan repeat surgery later once the media clarity improves a 
little, rather than doing more harm to the patient. Many a time’s visibility is the major 
concern in performing vitrectomy and extent of vitrectomy depends entirely upon the 
visualization.. There are several options: 
 Vitrectomy may be performed in a limited fashion, (“Proportional pars plana 
vitrectomy”[PPPV], a term coined by R. Morris).12 It is always better to perform vitreous 
tap with limited core vitrectomy rather than inflicting severe damage because of poor 
visualization. 
 A temporary keratoprosthesis (TKP) can be placed followed by implantation of donor 
cornea at the conclusion of surgery. If no donor cornea is available, even the original 
corneal button may be temporarily reused.  
 An endoscope may be utilized. But considerable experience is required on surgeon’s 
part and availability is also the major problem. 
Surgical procedure mentioned above cannot be applied to all the cases of endophthalmitis, 
as, post-traumatic and bleb related endophthalmitis are very difficult to manage and chronic 
endophthalmitis presents a very different clinical challenge to the clinician. So surgical 
modifications have to be adopted based on clinical presentation. 
9. Acute-onset postoperative endophthalmitis 
Acute postoperative endophthalmitis usually presents within 6 weeks of the surgery. It can 
present after any intraocular surgery, but it is most common after cataract surgery. Most 
common organism implicated is coagulase-negative staphylococci, but Staphylococcus aureus, 
the Streptococcus species, and gram-negative organisms can also cause postoperative 
endophthalmitis. As EVS study was done for post-operative endophthalmitis, so the results 
can be safely followed here. Early cases of endophthalmitis can be treated with vitreous TAP 
along with intravitreal antibiotics, but for severe cases PPV is the treatment of choice (figure 
1 a,b). Presenting visual acuity was the single most important factor in EVS predicting the  
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a. 
 
b. 
Fig. 1. Photographs of the left eye of 55 yr male presenting with acute endophthalmitis of 
bacterial origin a. Presenting VA: HM, IOP: 18 mmHg. Treatment: pars plana vitrectomy 
with intravitreal Vancomycin, Ceftazidime, and Dexamethasone. b. At 3 months VA:20/40, 
IOP:14 mmHg. 
final visual acuity. In EVS, 23% of patients with light perception acuity achieved 20/40 or 
better final acuity, compared with 64% of patients who had hand motions or better acuity. 
This data signifies the need for early treatment before severe visual loss happens (regardless 
whether TAP or vitrectomy is done). Once patient presents with severe visual loss, 
vitrectomy has better visual outcome and is the treatment of choice. Role of intravitreal 
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steroid is controversial in these cases. Since 90% of these cases are caused by bacteria, so 
early steroid administration reduces the inflammation and increases the chances of visual 
recovery (figure 2 a,b). In a prospective randomized clinical trial of 63 bacterial 
endophthalmitis cases Das et al, found that intravitreal dexamethasone reduces 
inflammation scores early in the course of treatment but had no independent influence on 
the final visual outcome.13 So the role of steroids is still controversial.  
 
a. 
 
b. 
Fig. 2. Photographs of the eye of 40 yr male presenting with acute postoperative 
endophthalmitis with scleral tunnel infiltrate (culture negative) a. Presenting VA: HM. 
Treatment: pars plana vitrectomy with intravitreal Vancomycin, Ceftazidime, 
Dexamethasone, tunnel resuturing. Patient received 4 IOAB + dexamethasone injections 
after initial PPV. b. At 3 months VA:20/60. 
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10. Delayed-onset or chronic postoperative endophthalmitis 
Endophthalmitis patients presenting after 6 weeks (months to year), are included in chronic 
endophthalmitis. They present not only with diagnostic challenge, but their management is 
vastly different from acute onset counterpart. Propionibacterium acnes, a gram-positive, 
anaerobic rod, is the most common organism causing chronic endophthalmitis. 
Characteristic feature of P.acne endophthalmitis is whitish capsular plaque (organisms 
mixed with residual lens cortex), which can be mistaken for posterior capsular opacification. 
Since organisms are residing inside capsular bag, simple vitrectomy with intravitreal 
antibiotics generally leads to inferior result with recurrence of infection. A pars plana 
vitrectomy and a central capsulectomy together with intravitreal antibiotics (vancomycin is 
the drug of choice) is generally recommended as the first line management.14–16 Vancomycin 
is injected into capsular bag at the end of the procedure. If infection is still not controlled; 
IOL removal along with complete bag removal is the treatment of choice. In clinically 
suspected fungal infections (2nd most common cause of chronic endophthalmitis) 
characterized by fluffy vitreous infiltrates with white snow ball like opacities, immediate 
injection of antifungal agents (intravitreal amphotericin B 5 μg or voriconazole 100 ug), is 
recommended after vitrectomy. If still infection is not controlled, total capsulectomy and 
IOL removal should be considered.17, 18 
11. Posttraumatic endophthalmitis 
In contrast to acute postoperative endophthalmitis, posttraumatic endophthalmitis carries 
worse prognosis (high severity of infection, polymicrobial etiology, associated pathologies 
e.g. IOFB, RD). Bacillus species, most commonly B. cereus, is the most common organism 
(cultured positivity 28% to 46%).19, 20 Endophthalmitis caused by Bacillus species is 
progressive, and generally carries a poor visual prognosis, even after immediate 
vitrectomy.21-23 Traumatic endophthalmitis esp. associated with retained intraocular foreign 
body (IOFB) carries the worst prognosis. In one study 3.5% patients with retained foreign 
bodies developed endophthalmitis when the primary surgical repair was accomplished 
within 24 hours of the injury compared with 13.4% patients in whom the primary surgical 
repair was delayed more than 24 hours.24 Further only 40.9% culture-positive cases achieved 
20/400 or better visual acuity necessitating the need for early vitrectomy and removal of 
IOFB. If retinal break or retinal detachment is also present, complete vitrectomy with 
endolaser of break with silicone oil injection is warranted to achieve good anatomical 
outcome. 
12. Endogenous endophthalmitis 
It is commonly seen in patients in whom body immunity is compromised e.g. chronic 
alcoholics, HIV patients, malignancy, renal transplant patients. Most common organisms 
implicated are bacteria or fungus (candida, aspergillus). The timing of and necessity for 
vitrectomy remains unclear in endogenous as compared with postoperative 
endophthalmitis. Vitrectomy will be more useful in posterior diffuse disease and severe 
disease (figure 3 a,b). In cases of fungal endophthalmitis, vitrectomy provides a good 
specimen for microbiology and effectively reduces the number of organisms. It is also 
crucial to consider the overall status of these individuals, many of whom will be desperately  
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a. 
 
b. 
Fig. 3. Photographs of the right eye of 22 yr male presenting with acute endogenous 
endophthalmitis (gram negative bacilli) a. Presenting VA: PL PR ACCURATE. Treatment: 
pars plana vitrectomy with intravitreal Vancomycin, Ceftazidime, and Dexamethasone. 
Patient developed RD for which PPV+EL+SIO was done. b. At 3 months VA:20/30. 
ill from systemic sepsis and anesthesia risk for surgery is very high. Despite aggressive 
antimicrobial therapy, most patients with endogenous endophthalmitis have a poor 
outcome. In a study from Singapore over a 4-year period, 17 of 32 affected eyes ended up 
with no light perception even after early surgical intervention.25  
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13. Bleb associated endophthalmitis 
The organisms frequently involved in this type of endophthalmitis include streptococcal 
species and Haemophilus influenzae. These organisms liberate potent toxins and tissue 
damaging enzymes that may contribute to virulence of intraocular infection and associated 
intraocular inflammation. The treatment of infections with such organisms poses serious 
problems. Even if the intraocular spaces are sterilised with appropriate antibiotics, a 
significant amount of bacterial debris and potentially toxic products remain to account for 
treatment failure. Hence pars plana vitrectomy and intraocular antibiotics are considered as 
the first line of management. Inspite of early and aggressive approach, visual outcome is not 
satisfactory. Song et al in their series of post bleb related endophthalmitis found that 
patients who underwent prompt pars plana vitrectomy (PPV)generally had a worse final 
visual outcome when compared with the tap/inject group.26 Busbee et al however found 
contrasting results with regard to treatment modality in the 68 patients with bleb associated 
endophthalmitis. Patients who underwent PPV had a greater likelihood of retaining 20/100 
vision or better at 12 months when compared with tap/inject (33% vs 13%, P = 0.09). 
Significantly higher rates of no light perception (NLP) vision were also seen in patients with 
a positive culture or who underwent tap/inject as primary treatment indicating early need 
for the vitrectomy.27 Dexamethasone can be used as along with antibiotics, as it will reduce 
the inflammatory damage induced by toxins thereby limiting the visual loss. However final 
visual acuity was same in dexamethasone receiving endophthalmitis group as well as in 
other group not receiving the drug as reported in literature.13, 27  
A brief summarization regarding the treatment and outcome of these types of 
endophthalmitis is given below (Table 5). 
 
 Acute Postop. 
Endophthalmitis
Delayed/Chronic 
Postop. 
Endophthalmitis 
Bleb Associated 
Endophthalmitis
Endogenous 
Endophthalmitis
Traumatic 
Endophthalmitis 
Causative 
organism  
Coagulase 
negative 
Staphylococci 
P.Acne, Fungi, 
Staphylococcus 
epidermidis 
Streptococcus, 
Hemophilus 
Bacteria, 
Fungi 
Bacilli, 
Fungi, 
Mixed 
Treatment 
of 
choice 
PPV/TAP+IOAB 
 
PPV ± IOL 
explantation ± 
Capsular bag 
removal + IOAB 
PPV + IOAB PPV/TAP + 
IOAB 
PPV+IOAB 
± additional  
procedure 
Indications 
of  
vitrectomy 
Severe infection, 
presenting vision 
PL±,  
worsening 
clinical picture  
Recurrent 
episodes, white 
capsular plaque, 
fungal 
etiology 
Mostly all cases Severe infection,
presenting 
vision PL±,  
worsening 
clinical picture  
Mostly preferred 
esp. associated 
with IOFB, 
suspected fungal 
etiology 
Prognosis Depends on 
initial visual 
Acuity, organism
virulence 
Variable Poor Poor Poor 
Table 5. Summarization of treatment option and prognosis of various types of 
endophthalmitis 
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14. Complications 
Vitrectomy procedure for endophthalmitis carries high complication rates because of several 
reasons. Various complications that commonly occur during vitrectomy are: 
1. Retinal break: Breaks can occur as a normal complication, as a direct injury from an 
intravitreal instrument, or as a result of aggressive vitrectomy to induce PVD. The 
breaks can be surrounded with laser or silicone oil may be used. 
2. Retinal Detachment: Retinal detachment can be rhegmatogenous (retinal break, 
surgical complication), tractional or exudative. Retina is very friable and necrotic in 
endophthalmitis, so chances of break formation with subsequent retinal detachment are 
very high. 
3. Vitreous hemorrhage 
4. Retinal toxicity from antibiotics 
5.  Phthisis bulbi 
In the EVS, major adverse events included retinal detachment in 5%, phthisis in 3%. 
Compared with TAP, vitrectomy was associated with a slightly lower rate of complications. 
Retinal detachment and phthisis occurred in 2.7% and 2% of vitrectomy eyes, respectively, 
compared to 7% and 4% of TAP group. However incidence of late additional surgical 
procedure did not differ whether vitrectomy was performed or initial procedure was TAP. 
The incidence of late additional surgical procedures was 27% overall.31 
15. Role of introcular tamponade 
Routine endophthalmitis surgery does not require any tamponade. However tamponade is 
necessary if any complication happens. Retinal with subsequent retinal detachment requires 
long term tamponade. Silicone oil can be used in cases where retinal break formation or 
retinal detachment has occurred. Not only it provides a long term tamponade, but it also 
retards the infectious process, as bacteria do not grow in silicone oil. However one should 
try to remove as much vitreous possible before injecting oil. Further doses of intravitreal 
injections has to be reduced (in general half the normal dosage), as oil prolongs their half-
life and if normal doses are injected there are high chances of retinal toxicity. 
Finally vitrectomy for endophthalmitis can also be done using suturless (23 or 25 gauge) 
system. There appears to be a trend toward the use of smaller gauge vitrectomy systems. 
Possible advantages include shorter operating time, reduced post operative inflammation 
from sutures in an already inflamed eye, reduced incidence of post operative retinal tears 
and detachments.28 Hilton et al; have evaluated office based suturless pars plana vitrectomy 
for various diseases including endophthalmitis with good success.29  
Tan et al, reviewed the outcomes of 23G vitrectomy in patients with postoperative 
endophthalmitis and found it to be a useful technique. There was no case of postoperative 
hypotony or wound leak.30 
In summary vitrectomy helps in debulking of vitreous, allowing dispersion of intra-ocular 
antibiotics and facilitating clearing of the visual pathway. Microbiological diagnosis is best 
made by culture of vitreous aspirate. Therapeutic vitrectomy is reserved for severe cases, 
defined as vitreous inflammation severe enough to obstruct view of the posterior pole on 
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indirect ophthalmoscopy, progressive inflammation despite initial antibiotic therapy, 
and/or cases that have not improved despite initial therapy. The need for additional 
procedures is a marker of more severe disease and is usually associated with worse visual 
outcomes. However, management of patients should be individualized and should be based 
on clinical judgment.  
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